Found 189 matching trials
Influence of Marker of Insulin Resistance Upon Hepatitis C Virus (HCV) Treatment Responses to PEG Intron and Rebetol Therapy PHASE4 The objective of this study is to better understand the influence of insuli...
Show More Location
Multiple Locations
Learn More & Join Trial
Adherence in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04281)(COMPLETED) N/A Patients receiving a patient assistance program during therapy for Hepatiti...
Show More Location
Multiple Locations
Learn More & Join Trial
Effect of Boceprevir on HCV-specific T Cell Responses N/A Analysis of HCV-specific T cell responses in patients treated with boceprev...
Show More Location
Unit of Infectious Diseases and Hepatology
Learn More & Join Trial
Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection PHASE3 Hepatitis C virus (HCV) infection is a leading cause of death and illness i...
Show More Learn More & Join Trial
Efficacy and Safety of Ypeginterferon Alfa-2b in Chronic Hepatitis C PHASE2 This study is a multi-center, randomized, open-label and positive controlle...
Show More Location
302 Military Hospital
Learn More & Join Trial
Evaluation of Satisfaction in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C (Study P04067) N/A The current gold standard for treatment of chronic hepatitis C (CHC) patien...
Show More Location
Multiple Locations
Learn More & Join Trial
Impact of Physician Directed Education on Patient Compliance With Hepatitis C Therapy PHASE4 The purpose of this study is to evaluate the impact of a physician directed...
Show More Location
California Liver Institute
Learn More & Join Trial
CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Relapsed Hepatitis C Virus (HCV) Subjects PHASE1 1. To characterize the tolerability profile of subcutaneous (SC) CPG 10101 ...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
Efficacy of PegInterferon-Ribavirin-Boceprevir Therapy in Patients Infected With G1 HCV With Cirrhosis, Awaiting Liver Transplantation PHASE2 Evaluation of efficacy of triple therapy with pegylated interferon, ribavir...
Show More Location
Haut-Lévêque Hospital
Learn More & Join Trial
Compliance of HCV Genotype 1 Infected Patients Receiving PegIntron/Rebetol and a Patient Assistance Program (Study P04671) N/A Enrolled patients will be recruited to two parallel groups during therapy f...
Show More Location
Multiple Locations
Learn More & Join Trial